title: Quality of life as a predictor for change in disability in MS.
authors.forename: M R
authors.initials: MR
authors.lastname: Haupts
authors.forename: C
authors.initials: C
authors.lastname: Hardt
authors.forename: D
authors.initials: D
authors.lastname: Pöhlau
authors.forename: B
authors.initials: B
authors.lastname: Sczesni
authors.forename: W
authors.initials: W
authors.lastname: Elias
authors.forename: H
authors.initials: H
authors.lastname: Langenbahn
authors.forename: H J
authors.initials: HJ
authors.lastname: Obert
authors.forename: P V
authors.initials: PV
authors.lastname: Wussow
mesh_terms: D004185:Disability Evaluation; D018450:Disease Progression; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology*; D011237:Predictive Value of Tests; D011788:Quality of Life; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins